Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda

PLoS Medicine(2021)10.1371/journal.pmed.1003492Source: DataRank Database

HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda is a research paper published in PLoS Medicine (2021). On theSindex it has a DataRank of 3.6. It has been cited 75 times, with 67 citing works in its 1-hop citation network.

N/A

3.6DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access75 citations · 67 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT01864603

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)OA: goldTopics (97)IDs (PubMed, PMC)Annotations (1)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 18%Citation Network 82%

Base Score Contribution

0.650

From this paper's citation signal

Citation Network Contribution

2.9

From 52 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 67 citers.

Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study
The Lancet HIV202258 citations21 referencesContributes 0.194
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China
JAMA Network Open202243 citations23 referencesContributes 0.165
Increased PrEP uptake and PrEP-RN coincide with decreased HIV diagnoses in men who have sex with men in Ottawa, Canada
Canada Communicable Disease Report202318 citations22 referencesContributes 0.134
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study
The Lancet HIV202281 citations33 referencesContributes 0.134
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis
The Lancet Global Health202315 citations23 referencesContributes 0.121

Authors (30)

Diane V. Havlir ORCID,James Ayieko ORCID,Dalsone Kwarisiima ORCID,Jane Kabami ORCID,Gabriel Chamie ORCID

Live enrichment

PubMed:33561143 PMC:PMC7872279

National Institute of Allergy and Infectious Diseases

Grant: U01AI099959

National Institute of Allergy and Infectious Diseases

Grant: UM1AI068636

National Institute of Allergy and Infectious Diseases

Grant: 2R01AI098472

National Institute of Mental Health

Grant: K23MH114760

Bill and Melinda Gates Foundation

Grant: OPP1159068

NIAID NIH HHS

Grant: R01 AI098472

NIAID NIH HHS

Grant: P30 AI027763

National Institutes of Health

Grant: 3UM1AI068636-19SC

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

National Institutes of Health

Grant: 4R01AI098472-05

Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials

National Institutes of Health

Grant: 1K23MH114760-01A1

Optimizing Adherence to PrEP among Young African Women through a Community Adherence Club Intervention

National Institutes of Health

Grant: 3U01AI099959-03S1

Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)

National Institutes of Health

Grant: 5R01LM013039-02

HealthyMe/MiSalud Smartphone Application: Identifying Mechanisms to Engage African Americans and Hispanics in Personal Health Libraries

PEPFAR

Influential Citations

goldLicense: cc-by

GOLDhttps://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003492&type=printable

publisherhttps://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003492&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pmed.1003492

repositoryhttps://hdl.handle.net/20.500.14394/3758

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7872279

Fields of Study

Medicine0302 clinical medicine03 medical and health sciencesAdolescentAdultAgedAged, 80 and overAnti-HIV AgentsFemaleHIV InfectionsHomosexuality, MaleHumansIncidenceKenyaMaleMedication AdherenceMiddle AgedPre-Exposure ProphylaxisRiskSex FactorsTenofovirUgandaYoung Adult

MeSH Terms

HumansHIV InfectionsAnti-HIV AgentsIncidenceRiskHomosexuality, MaleSex FactorsAdolescentAdultAgedAged, 80 and overMiddle AgedKenyaUgandaFemaleMaleMedication AdherenceYoung AdultPre-Exposure ProphylaxisTenofovir

Keywords

MaleBiomedical and clinical sciencesLEVELHIV InfectionsMedical and Health SciencesINFECTION80 and overMedicine and Health Sciences2.1 Biological and endogenous factorsUganda360Aged, 80 and overIncidenceR600HomosexualityMiddle AgedInfectious DiseasesMedical MicrobiologyHIV/AIDSMedicineFemalePublic HealthResearch ArticleAdultRiskAdolescentAnti-HIV AgentsTRANSMISSIONClinical SciencesClinical Trials and Supportive Activities610Medication AdherenceYoung AdultSex FactorsADHERENCEClinical ResearchGeneral & Internal MedicineHealth SciencesBehavioral and Social ScienceInternal MedicineHumansHomosexuality, MaleTenofovirAgedDRUG-RESISTANCEPreventionKenyaGood Health and Well BeingVIRAL LOADSexually Transmitted InfectionsWomen's Health3.1 Primary prevention interventions to modify behaviours or promote wellbeingPre-Exposure Prophylaxis

Sustainable Development Goals

SDG 1: 1. No povertySDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 16: 16. Peace & justice